65
Views
13
CrossRef citations to date
0
Altmetric
Original Research

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

, , , , &
Pages 5899-5906 | Published online: 12 Dec 2017

References

  • HanZFengJHongZSilencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cellsBiochem Biophys Res Commun2013435218819423665025
  • ChenWZhengRZhangSReport of incidence and mortality in China cancer registries, 2009Chin J Cancer Res2012253171180
  • YenMSJuangCMLaiCRChaoGCNgHTYuanCCIntraperitoneal DDP-based chemotherapy vs intravenous DDP-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancerInt J Gynaecol Obstet2001721556011146078
  • BoulikasTVougioukaMCisplatin and platinum drugs at the molecular level. (Review)Oncol Rep20031061663168214534679
  • ChuGCellular responses to DDP. The roles of DNA-binding proteins and DNA repairJ Biol Chem199426927877908288625
  • ThigpenTduBoisAMcalpineJGynecologic Cancer Inter-GroupFirst-line therapy in ovarian cancer trialsInt J Gynecol Cancer201121475676221543937
  • KigawaJNew Strategy for overcoming resistance to chemotherapy of ovarian cancerYonago Acta Med2013562435024031151
  • AzmiASWangZBurikhanovRCritical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosisMol Cancer Ther2008792884289318790769
  • RosenDGYangGLiuGOvarian cancer: pathology, biology, and disease modelsFront Biosci (Landmark Ed)2009142089210219273186
  • BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
  • NamEJYoonHKimSWMicroRNA expression profiles in serous ovarian carcinomaClin Cancer Res20081492690269518451233
  • WangZTingZLiYChenGLuYHaoXmicroRNA-199a is able to reverse DDP resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycinOncol Lett20136378979424137412
  • SemenzaGLInvolvement of hypoxia-inducible factor 1 in human cancerIntern Med2002412798311868612
  • SemenzaGLTargeting HIF-1 for cancer therapyNat Rev Cancer200331072173213130303
  • ZhongHDe MarzoAMLaughnerEOverexpression of hypoxia-inducible factor 1α in common human cancers and their metastasesCancer Res199959225830583510582706
  • JoshiHSubramanianIGhoshGZengYZhaoMRamakrishnanSAbstract 2070: Mir-199a is downregulated in hypoxia and targets HIF1α in ovarian cancer cellsCancer Res2010708 Suppl2070
  • SchmittgenTDLivakKJAnalyzing real-time PCR data by the comparative CT methodNat Protoc2008361101110818546601
  • MaternaVLiedertBThomaleJLageHProtection of platinum-DNA adduct formation and reversal of DDP resistance by anti-MRP2 hammerhead ribozymes in human cancer cellsInt J Cancer2005115339340215688364
  • GalluzziLSenovillaLVitaleIMolecular mechanisms of DDP resistanceOncogene201231151869188321892204
  • TanLKwokRPShuklaATrichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cellsCancer2011117478479420925046
  • KongFSunCWangZmiR-125b confers resistance of ovarian cancer cells to DDP by targeting pro-apoptotic Bcl-2 antagonist killer 1J Huazhong Univ Sci Technolog Med Sci201131454354921823019
  • RaoYMShiHRJiMChenCHMiR-106a targets Mcl-1 to suppress DDP resistance of ovarian cancer A2780 cellsJ Huazhong Univ Sci Technol Med Sci201333456757223904379
  • ChenRAlveroABSilasiDARegulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cellsOncogene200827344712472318408758
  • ZuberiMKhanIGandhiGRayPCSaxenaAThe conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancerTumor Biol20163781125911266
  • WangZZhouTYaLIChenGYunpingLUHaoXmicroRNA-199a is able to reverse DDP resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycinOncol Lett20136378979424137412
  • RameshGReevesWBTNF-alpha mediates chemokine and cytokine expression and renal injury in DDP nephrotoxicityJ Clin Invest2002110683584212235115
  • AdamsJMCorySThe Bcl-2 apoptotic switch in cancer development and therapyOncogene20072691324133717322918
  • CullenKJYangZSchumakerLGuoZMitochondria as a critical target of the chemotheraputic agent DDP in head and neck cancerJ Bioenerg Biomembr2007391435017318397
  • Sánchez-GonzálezPDLópez-HernándezFJLópez-NovoaJMMoralesAIAn integrative view of the pathophysiological events leading to DDP nephrotoxicityCrit Rev Toxicol2011411080382121838551
  • ThorburnADeath receptor-induced cell killingCell Signal200416213914414636884
  • TsuruyaKNinomiyaTTokumotoMDirect involvement of the receptor-mediated apoptotic pathways in DDP-induced renal tubular cell deathKidney Int2003631728212472770
  • RaneSHeMSayedDDownregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytesCirc Res2009104787988619265035
  • MizunoSBogaardHJGomez ArroyoJMicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPDChest2012142366367222383663
  • DingGHuangGLiuHDMiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1αMol Cell Biochem20133841–217318024022342